| [1] | 叶胜龙，秦叔逵.原发性肝癌规范化诊治的专家共识[J].肿瘤,2009,29 (4):295-304. |
| [2] Carrilho FJ, Kikuchi L, Branco F, et al. Clinical andepidemiological aspects of hepatocellular carcinoma in Brazil [J].Clinics (Sao Paulo), 2010, 65 (12):1285-1290. | |
| [3] Bartolomeo N,Trerotoli P, Serio G. Progression of liver cirrhosis toHCC:an application of hidden Markov model[J].BMC Med ResMethodoL 2011，11:38. | |
| [4] 叶胜龙，陈荣新.2010年美国肝病学会肝细胞癌临床指南更新版解读[J/CD].中国医学前沿杂志:电子版,2011,3 (1):17-20. | |
| [5] Qu ZL, Zou SQ, Cui NQ, et al. Upregulation of human telomerasereverse transcriptase mRNA expression by in vitro transfection ofhepatitis B virus X gene into human hepatocarcinoma andcholangiocarcinoma cells.World J Gastroenterol, 2005,11 (36):5627-5632. | |
| [6] Chan HL.,JGH Foundation emerging leadership lecture. Significanceof hepatitis B virus genotypes and mutations in the development ofhepatocellular carcinoma in Asia[J].Eur J Gastroenterol Hepatol2011,26(1):8-12. | |
| [7] Bruix J,Sherman M. Management of hepatocellular carcinoma:anupdate[J].Hepatology, 2011,53 (3):1020-1022. | |
| [8] Borie F, Tretarre B, Bouvier AM, et al. Primitive liver cancers:epidemiology and geographical study in Prance [J].Eur JGastroenterol Hepatoh 2009, 21 (9):984-989. | |
| [9] Zhou XD,Tang ZY,Fan J, et al. Intrahepatic cholangiocarcinoma:report of 272 patients compared with 5829 patients withhepatocellular carcinoma[J].Cancer Res Clin Oncol, 2009,135 (8):1073-1080. | |
| [10] Cui R，He J, Zhang F, et al. Diagnostic value of protein inducedby vitamin K absence (P1VKAII) and hepatoma-specific band ofserum gamma-glutamyl transferase(GGTII)as hepatocellularcarcinoma markers complementary to alpha-fetoprotein[J].Br,JCancer,2003,88(12):1878-1882. |